TaiGen Biopharmaceuticals Holdings (太景醫藥研發控股股份有限公司) is a company that focuses on the development of therapeutics for diseases such as cancer, infections, and diabetic complications. It is involved in drug discovery, clinical trials, regulatory approval, and global product commercialization, with a pipeline that includes internally developed and in-licensed programs.